Medicine

A tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson's disease and related disorders.

Researchers have developed a new biological sensing method that can detect substances at miniscule amounts, which is immediately useful for drug testing and other research.

Researchers from University of Arizona Health Sciences are one step closer to solving one of the biggest barriers to regenerative medicine: immunological rejection by the recipient.

University of Arizona immunologist Deepta Bhattacharya discusses in this Q&A the newest COVID-19 vaccines and what the future might hold for COVID-19 immunizations.

Researchers have learned more about the part of the brain that mediates satiation. This could help lead to better treatments for eating disorders and weight management.

UArizona researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy has been licensed to startup NeuTherapeutics Inc. 

An engineering graduate student developed a system to help mitigate no-shows for health care appointments.

A team of researchers at the University of Arizona is developing new methods to collect and analyze sweat for clues about how the body is functioning.

With funding from the National Cancer Institute, a team of researchers at the University of Arizona Cancer Center is seeking effective preventive and therapeutic strategies to reduce the risk of non-melanoma skin cancer, like squamous cell carcinoma of the skin.

A therapeutic intervention for amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, could be on the horizon thanks to unexpected findings by UArizona researchers.